Okumura K. | Dept Immunol., Juntendo Univ., Sch., Med.
スポンサーリンク
概要
関連著者
-
Yahata T.
′ Sec.Genetic Eng., Res. Cent.Genetic Eng. and Cell Transplant.,′ Tokai Univ., Sch .Med.
-
Okumura K.
Dept Immunol., Juntendo Univ., Sch., Med.
-
Iwakabe K.
′ Section Of Genetic Engineering Research Center For Genetic′ Engineering And Cell Transplantation T
-
Sekimoto M.
Section Of Genetic′ Engineering Research Center For Genetic Engineering And Cell′ Transplantation To
-
Takeda K.
Division′ Of Immunoregulation Institute For Genetic Medicine Hokkaido′ University
-
Nishimura T.
Section Of Genetic′ Engineering Research Center For Genetic Engineering And Cell′ Transplantation To
-
Kitamura H.
Section Of Genetic′ Engineering Research Center For Genetic Engineering And Cell′ Transplantation To
-
Van Kaer
′ Howard Hughes Med.inst. Dept. Microbiol. And Immunol. ′ Vandertment Univ. Sch. Med.
-
Van Kaer
Howard Hughes Medical Institute ′ Department Of Microbiology And Immunology Vanderbilt′ University S
-
Van Kaer
Howard Hugesmedical Institute Department Of Microbiology And Immunology Vanderbilt University Scool
-
Okumura K.
Department of HospitalPharmacy, School of Medicine, Kobe University
-
Takeda K.
Dept. of Med.. Div. of Hypertension and Cardiorenal Disease, Dokkyo Univ. School of Med.
-
Nishimura T.
Div. Immunoreg., Sec.Disease Cont.,Inst.Genetic Med., Hokkaido′ Univ. and Sec.Genetic Eng., Res. Cen
-
Kitamura H.
Sec.Genetic Eng.,and Cell′ Transplant., Tokai Univ.,Sch.Med
-
Iwakabe K.
Sec.Genetic Eng.,Res.Cent.′ Genetic Eng.and Cell Transplant., Tokai Univ., Sch. Med.
-
Ohta A.
Div.Immunoreg.,Sec Disease Cont.,′ Inst.Genetic Med., Hokkaido Univ and Sec. Genetic Eng.,′ Res. Cen
-
′ Sato
Sec.Genetic Eng., Res.Cent. Genetic Eng.and Cell′ Transplant., Tokai Univ., Sch. Med.
-
Kawano T.
CREST Project and Dept.Mol.Immunol.,′ Grad.Sch. Med., Chiba Univ.
-
′ Taniguchi
CREST Project and Dept. Mol.′ Immunol., Grad.Sch.Med., Chiba Univ.
-
Nakui M.
Sect. Genetic Eng.,′ Res. Cent. Genetic Eng.and Cell Transplant., Tokai Univ.,′ Sch.Med.
-
Sekimoto M.
Div.Immunoreg., Sec.Disease Cont.,Inst.′ Genetic Med.,Hokkaido Univ.Sec.Genetic Eng., Res. Cent.′ Ge
-
Koda T.
′ Sec.Genetic Eng., Res. Cent.Genetic Eng.and Cell Transplant.,′ Tokai Univ.,Sch.Med.′ Hokkaido Univ
-
Nakui M.
Section Of Genetic Engineering Research Center For Genetic′ Engineering And Cell Transplantation And
-
Kitamura H.
Section of Genetic′ Engineering, Research Center for Genetic Engineering and′ Cell Transplantation,
-
Sato M.
Section of Genetic′ Engineering, Research Center for Genetic Engineering and′ Cell Transplantation,
-
Nishimura T.
Section of Genetic′ Engineering, Research Center for Genetic Engineering and′ Cell Transplantation,
-
Yahata T.
′ Sec.genetic Eng. Res. Cent.genetic Eng. And Cell Transplant. ′ Tokai Univ. Sch .med.
-
Ohmi Y.
Section Of Genetic Engineering ′ Research Center For Genetic Engineering And Cell′ Transplantation
-
Nishimura S.
Division of Biological Science, Graduate School of′ Science, Hokkaido University′ Hokkaido Universit
-
Iwakabe K.
Department of Immunology, Tokai University′ School of Medicine
-
Yahata T.
Department of Immunology, Tokai′ University School of Medicine
-
Ohta ′
′ Section of Genetic Engineering Research Center for Genetic′ Engineering and Cell Transplantation
-
Takeda K.
′ Department of Immunology, Juntendo University School of′ Medicine
-
Kawano T.
Core Research for Evolutional′ Science and Technology (CREST) project and Department of′ Molecular I
-
Taniguchi M.
Core Research for Evolutional Science and′ Technology (CREST) project and Department of Molecular′ I
-
Ohta A.
Section of′ Genetic Engineering, Research Center for Genetic Engineering′ and Cell Transplantation, Tokai University School of Medicine′ and Division of Immunoregulation, Institute for Genetic′ Medicine, Hokkaido University
著作論文
- The interface between innate and acquired immunity: glycolipid′ antigen presentation by CD1d-expressing dendritic cells to′ NKT cells induces the differentiation of antigen-specific′ cytotoxic T lymphocytes.
- The natural killer T (NKT) cell ligand _-galactosylceramide′ demonstrates its immunopotentiating effect by inducing′ intreleukin (IL)-12 production by dendritic cells and IL-12′ receptor expression on NKT cells.